Investing.com - UBS has lowered its price target on Neurocrine Biosciences (NASDAQ:NBIX) to $188.00 from $195.00 while maintaining a Buy rating on the stock. Currently trading at $137.42, Neurocrine ...

Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, ...

How does the CS2 ranks and rating system work? Competitive Counter-Strike is drastically changing in CS2 to create a more streamlined experience depending on how you prefer to play the game. There are ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Thibault Spirlet Every time Thibault publishes a story, you’ll get an alert straight to your ...

Laughing Water Capital, an investment management company, released its fourth-quarter 2025 investor letter. In the quarter, Laughing Water Capital returned ~6.8%, bringing the full-year returns to ...